NIH Funding Opportunities (Notices, PA, RFA)

Subscribe to NIH Funding Opportunities (Notices, PA, RFA) feed
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 39 min 10 sec ago

New Investigator Gateway Awards for Collaborative T1D Research (R03 Clinical Trial Not Allowed)

Wed, 2025-01-22 09:44
Funding Opportunity RFA-DK-26-009 from the NIH Guide for Grants and Contracts. The New Investigator Gateway Award in T1D Research is designed to supporta robust pipeline of innovative projects and talented new investigators in T1D research. In addition to providing support for preliminary research, the Gateway program provides an opportunity for new Program Directors/Principal Investigators (PD/PIs) to pursue their studies within the intellectual environment of a select number of large, ongoing collaborative research programs. Embedding awardees within an established scientific framework in each of these consortia will provide unique opportunities for New andEarly Stage Investigators to increase their understanding of key questions in the field, to network, and to establish unique and potentially long-lasting collaborations that will propel their careers forward. Bringing New and Early Stage Investigators into existing collaborative research networks will also benefit the networks by providing new ideas and perspectives.

Notice to Extend Expiration dates for AHRQ PA-22-049 and PA-22-050

Tue, 2025-01-21 11:00
Notice NOT-HS-25-013 from the NIH Guide for Grants and Contracts

NIA Postdoctoral Fellowship Award to Promote Broad Participation in Translational Research for AD/ADRD (F32 Clinical Trial Not Allowed)

Fri, 2025-01-17 12:00
Funding Opportunity PAR-24-332 from the NIH Guide for Grants and Contracts. The purpose of this Notice for Funding Opportunity (NOFO) is to promote diversity in the translational research workforce for Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). This postdoctoral fellowship will support research training of promising postdoctoral candidates from diverse backgrounds, and emphasize the development of translational research skills and their application to various aspects of AD/ADRD research (from populations studies to research that can lead to new treatments and diagnostics, including all aspects of behavioral and social research). The long-term goal of this program is to develop a diverse translational workforce that can effectively participate in and/or lead a team-science, interdisciplinary approach to studies of AD/ADRD treatment, prevention, early detection, and disease management and care. is designed for candidates proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial. Under this NOFO candidates are permitted to propose a research experience in a clinical trial led by a mentor or co-mentor.

Notice of Information: Re-issue of Longstanding NHLBI T32 Program

Fri, 2025-01-17 11:37
Notice NOT-HL-25-005 from the NIH Guide for Grants and Contracts

Notice of Special Interest (NOSI): Addressing Cancer-Related Financial Hardship to Improve Patient Outcomes

Fri, 2025-01-17 10:58
Notice NOT-CA-25-035 from the NIH Guide for Grants and Contracts

Notice to Rescind NOT-CA-18-031 "NIH Applicant Assistance Program (AAP) for New or Previously Unawarded Small Businesses"

Fri, 2025-01-17 10:26
Notice NOT-OD-25-065 from the NIH Guide for Grants and Contracts

NIA Predoctoral Fellowship Award to Promote Broad Participation in Translational Research for AD/ADRD (F31 Clinical Trial Not Allowed)

Fri, 2025-01-17 10:21
Funding Opportunity PAR-24-333 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to promote diversity in the translational research workforce for Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). This predoctoral fellowship program will support research training of promising predoctoral candidates from diverse backgrounds and emphasize the development of translational research skills and their application to various aspects of AD/ADRD research (from populations studies to research that can lead to new treatments and diagnostics, including all aspects of behavioral and social research). The long-term goal of this program is to develop a diverse translational workforce that can effectively participate in and/or lead a team-science, interdisciplinary approach to studies of AD/ADRD treatment, prevention, early detection, and disease management and care.

Notice of Clarification to PAR-24-272 "Clinical and Translational Science Award (UM1 Clinical Trial Optional)"

Fri, 2025-01-17 10:11
Notice NOT-TR-25-006 from the NIH Guide for Grants and Contracts

Pages